CLSA Raises Target Price for WUXI XDC to HK$80.9, Citing Improved Profit Visibility

Stock News03-25

CLSA released a research report stating that WUXI XDC's (02268) second-half performance last year met expectations, while its 2026 guidance exceeded expectations. Management forecasts at least 35% revenue growth at constant exchange rates, including BioDlink, and at least 40% growth in CDMO revenue excluding BioDlink, with margins expected to remain largely stable year-on-year. The firm projects WUXI XDC's revenue growth from this year to 2028 to be 38%, 31%, and 28%, respectively. Net profit forecasts have been raised by 6% to 13%, and the target price has been increased from HK$70.7 to HK$80.9, with an "Outperform" rating reaffirmed. The report noted that WUXI XDC reiterated its target for an average annual revenue compound growth rate of 30% to 35% from 2025 to 2030, with a CMO portfolio target of 20% by 2030. Order backlog growth for 2025 is projected at 50%. CLSA believes this enhances the company's profit visibility and alleviates investor concerns about slowing growth.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment